Pulmonary well-differentiated fetal adenocarcinoma with platelet-derived growth factor receptor (PDGFR)α expression

References

• Kradin RL, Young RH, Dickersin GR, Kirkham SE, Mark EJ. Pulmonary blastoma with argyrophil cells and lacking sarcomatous features (pulmonary endodermal tumor resembling fetal lung). Am J Surg Pathol 1982; 6:165 - 72; http://dx.doi.org/10.1097/00000478-198203000-00009; PMID: 6179430
   PubMed Web of Science ®Google Scholar
• Sato S, Koike T, Yamato Y, Yoshiya K, Honma K, Tsukada H. Resected well-differentiated fetal pulmonary adenocarcinoma and summary of 25 cases reported in Japan. Jpn J Thorac Cardiovasc Surg 2006; 54:539 - 42; http://dx.doi.org/10.1007/s11748-006-0048-8; PMID: 17236658
   PubMedGoogle Scholar
• Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6:244 - 85; http://dx.doi.org/10.1097/JTO.0b013e318206a221; PMID: 21252716
   PubMed Web of Science ®Google Scholar
• Valius M, Kazlauskas A. Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor’s mitogenic signal. Cell 1993; 73:321 - 34; http://dx.doi.org/10.1016/0092-8674(93)90232-F; PMID: 7682895
   PubMed Web of Science ®Google Scholar
• Williams LT. Signal transduction by the platelet-derived growth factor receptor. Science 1989; 243:1564 - 70; http://dx.doi.org/10.1126/science.2538922; PMID: 2538922
   PubMed Web of Science ®Google Scholar
• McDermott U, Ames RY, Iafrate AJ, Maheswaran S, Stubbs H, Greninger P, et al. Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors. Cancer Res 2009; 69:3937 - 46; http://dx.doi.org/10.1158/0008-5472.CAN-08-4327; PMID: 19366796
   PubMed Web of Science ®Google Scholar
• Zhang P, Gao WY, Turner S, Ducatman BS. Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro. Mol Cancer 2003; 2:1; http://dx.doi.org/10.1186/1476-4598-2-1; PMID: 12537587
   PubMed Web of Science ®Google Scholar
• Zaidi A, Zamvar V, Macbeth F, Gibbs AR, Kulatilake N, Butchart EG. Pulmonary blastoma: medium-term results from a regional center. Ann Thorac Surg 2002; 73:1572 - 5; http://dx.doi.org/10.1016/S0003-4975(02)03494-X; PMID: 12022552
   PubMed Web of Science ®Google Scholar
• Nakatani Y, Kitamura H, Inayama Y, Kamijo S, Nagashima Y, Shimoyama K, et al. Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol 1998; 22:399 - 411; http://dx.doi.org/10.1097/00000478-199804000-00003; PMID: 9537466
   PubMed Web of Science ®Google Scholar
• Koss MN, Hochholzer L, O’Leary T. Pulmonary blastomas. Cancer 1991; 67:2368 - 81; http://dx.doi.org/10.1002/1097-0142(19910501)67:9<2368::AID-CNCR2820670926>3.0.CO;2-G; PMID: 1849449
   PubMed Web of Science ®Google Scholar
• Zhang H, Bajraszewski N, Wu E, Wang H, Moseman AP, Dabora SL, et al. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J Clin Invest 2007; 117:730 - 8; http://dx.doi.org/10.1172/JCI28984; PMID: 17290308
   PubMed Web of Science ®Google Scholar
• Tallquist M, Kazlauskas A. PDGF signaling in cells and mice. Cytokine Growth Factor Rev 2004; 15:205 - 13; http://dx.doi.org/10.1016/j.cytogfr.2004.03.003; PMID: 15207812
   PubMed Web of Science ®Google Scholar
• Gazit A, Igarashi H, Chiu IM, Srinivasan A, Yaniv A, Tronick SR, et al. Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell 1984; 39:89 - 97; http://dx.doi.org/10.1016/0092-8674(84)90194-6; PMID: 6091919
   PubMed Web of Science ®Google Scholar
• Knösel T, Chen Y, Altendorf-Hofmann A, Danielczok C, Freesmeyer M, Settmacher U, et al. High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. J Cancer Res Clin Oncol 2012; 138:397 - 403; http://dx.doi.org/10.1007/s00432-011-1107-9; PMID: 22160160
   PubMed Web of Science ®Google Scholar
• MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C, Chen Y, et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 2001; 29:143 - 52; http://dx.doi.org/10.1038/ng731; PMID: 11544480
   PubMed Web of Science ®Google Scholar
• Corless CL, Schroeder A, Griffith D, Town A, McGreevey L, Harrell P, et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 2005; 23:5357 - 64; http://dx.doi.org/10.1200/JCO.2005.14.068; PMID: 15928335
   PubMed Web of Science ®Google Scholar
• Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G, et al. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 2002; 8:3034 - 8; PMID: 12374669
   PubMed Web of Science ®Google Scholar
• Yamazaki K. Pulmonary well-differentiated fetal adenocarcinoma expressing lineage-specific transcription factors (TTF-1 and GATA-6) to respiratory epithelial differentiation: an immunohistochemical and ultrastructural study. Virchows Arch 2003; 442:393 - 9; PMID: 12684771
   PubMed Web of Science ®Google Scholar
• Nakatani Y, Miyagi Y, Takemura T, Oka T, Yokoi T, Takagi M, et al. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. Am J Surg Pathol 2004; 28:921 - 7; http://dx.doi.org/10.1097/00000478-200407000-00012; PMID: 15223963
   PubMed Web of Science ®Google Scholar
• Heldin CH, Westermark B. Platelet-derived growth factor: three isoforms and two receptor types. Trends Genet 1989; 5:108 - 11; http://dx.doi.org/10.1016/0168-9525(89)90040-1; PMID: 2543106
   PubMed Web of Science ®Google Scholar
• El Ouazzani H, Jniene A, Bouchikh M, Achachi L, El Ftouh M, Achir A, et al. Well-differentiated fetal adenocarcinoma: a very uncommon malignant lung tumor. Rev Port Pneumol 2012; 18:39 - 41; http://dx.doi.org/10.1016/j.rppneu.2011.06.003; PMID: 21778030
   PubMed Web of Science ®Google Scholar
• Van Loo S, Boeykens E, Stappaerts I, Rutsaert R. Classic biphasic pulmonary blastoma: a case report and review of the literature. Lung Cancer 2011; 73:127 - 32; http://dx.doi.org/10.1016/j.lungcan.2011.03.018; PMID: 21513998
   PubMed Web of Science ®Google Scholar
• Fujino S, Asada Y, Konishi T, Asakura S, Kato H, Mori A. Well-differentiated fetal adenocarcinoma of lung. Lung Cancer 1995; 13:311 - 6; http://dx.doi.org/10.1016/0169-5002(95)00489-0; PMID: 8719071
   PubMed Web of Science ®Google Scholar
• Lee HJ, Goo JM, Kim KW, Im JG, Kim JH. Pulmonary blastoma: radiologic findings in five patients. Clin Imaging 2004; 28:113 - 8; http://dx.doi.org/10.1016/S0899-7071(03)00240-7; PMID: 15050223
   PubMed Web of Science ®Google Scholar
• Pilla ES, Sanchez P, Mädke GR, Camargo S, Camargo JdeJ. Pulmonary blastoma: treatment through sleeve resection of the right upper lobe. J Bras Pneumol 2006; 32:75 - 7; http://dx.doi.org/10.1590/S1806-37132006000100014; PMID: 17273572
   PubMedGoogle Scholar
• Longo M, Levra MG, Capelletto E, Billè A, Ardissone F, Familiari U, et al. Fetal adenocarcinoma of the lung in a 25-year-old woman. J Thorac Oncol 2008; 3:441 - 3; http://dx.doi.org/10.1097/JTO.0b013e318169cd9a; PMID: 18379367
   PubMed Web of Science ®Google Scholar
• Wang J, Sun H, Bai R, Liu H, Yu T. Pulmonary blastoma with endobronchial growth. J Thorac Oncol 2009; 4:543 - 4; http://dx.doi.org/10.1097/JTO.0b013e31819c8646; PMID: 19333073
   PubMed Web of Science ®Google Scholar
• Cheng C, Liu ZG, Zhang H, Xie JD, Chen XG, Zhao XQ, et al. Enhancing chemosensitivity in abcb1- and abcg2-overexpressing cells and cancer stem-like cells by an aurora kinase inhibitor cct129202. Mol Pharm 2012; http://dx.doi.org/10.1021/mp2006714; PMID: 22632055
   PubMed Web of Science ®Google Scholar